Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Laura Goff

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI16149

    11/10/2017

    An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects with Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

    Treatment

    VICCMD16159

    11/07/2017

    A Phase 1/2 Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of Azacitidine in Combination with Pembrolizumab and Epacadostat in Subjects with Advanced Solid Tumors and Previously Treated Stage IIIB or Stage IV Non?Small Cell Lung Cancer and Stage IV Microsatellite-Stable Colorectal Cancer

    Treatment

    VICCGI1721

    06/23/2017

    A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of AG-120 in Previously-Treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

    Treatment

    VICCGI1655

    12/14/2016

    A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer


    Print this page for your doctor